FENOSTAL 0.5

FENOSTAL 0.5

- The active component of Fenostal® is Dimethindene 
   maleate which is a phenindene derivative and is 
   histamine antagonist at the H1 receptor level and is 
   reported to have mast-cell stabilizing properties.
- In addition Dimethindene maleate has antikinin activity, a 
  slight anticholinergic and sedative effect.
- Accordingly it reduces the capillary hyperpermeability 
  associated with immediate hypersensitivity reactions.

- Each 5 ml of Fenostal® Oral solution contains:
  Dimethindene maleate    0.5 mg
- Each 1 ml of Fenostal® Oral Drops contains:
  Dimethindene maleate    1 mg

- Hypersensitivity to Dimethindene maleate.
- Babies of less than one month of age.

- You should only use Fenostal® during pregnancy or 
   lactation if advised to do so by the doctor.

- Frequently: drowsiness, especially at high doses.
- Occasionally: nausea, dryness of mouth or throat, 
  vertigo and headaches.
- Rarely: edema, cutaneous eruptions, muscular spasm 
  and respiratory disturbances.

- Antihistamines can cause excitation in young children.
- Observe the customary precautions in case of narrow 
  angle glaucoma, urinary retention linked with 
  urethra-prostatic disorders and of chronic obstructive 
  pulmonary disorders.
- Caution is recommended in case of administration of the 
  syrup to the infants below the age of 1 year as the 
  sedative effect can be associated with episodes of sleep 
  apnea.
- This medication can affect reactions, the ability to drive 
   and the ability to use tools or machinery.
 

- Fenostal® oral solution: Bottle of 100 ml.
- Fenostal® oral drops: Bottle of 20 ml with 
  measuring dropper.
 

-Store at temperature below 30°C, protected from light.